Quality-of-life measurement in women with breast cancer

Breast Journal

Volumn 3, Issue 4, 1997, Pages 178-186

  McQuellon, Richard P ^a,b   Kimmick, Gretchen ^a   Hurt, Gail J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b North Carolina Baptist Hospital   (United States)

Author keywords

Breast cancer; Quality of life

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL PRACTICE; DATA BASE; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; QUALITY OF LIFE; RELIABILITY; TREATMENT OUTCOME; WELLBEING;

EID: 0030752491     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4741.1997.tb00163.x     Document Type: Article

References (22)

1. Cella DF, Bonomi AE. Measuring quality of life: 1995 update. Oncology 1995;9:47-60.
2. Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest 1993;11:327-36.
3. McCabe MS. A cooperative group report on quality of life research: lessons learned. Monogr Natl Cancer lust 1996; 63-65.
4. Aaronson NK. Assessment of quality of life and benefits from adjuvant therapies in breast cancer. Recent Results Cancer Res 1993;127:201-10.
5. Aaronson NK, Meyerowitz BE, Bard M, et al. Quality of life research in oncology. Past achievements and future priorities. Cancer 1991;67:83-93.
6. Glanz K, Lerman C. sychosocial impact of breast cancer: a critical review. Ann Behav Med 1992;14:204-12.
7. Beitz J, Gnecco C, Justice R. Quality of life endpoints in cancer clinical trials: the U.S. food and drug administration perspective. Monogr Natl Cancer Inst 1996;7-9.
8. Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985;69:1155-59.
9. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines.J Clin Oncol 1996;14: 671-79.
10. Meyerowitz BE. Psychosocial correlates of breast cancer and its treatments. Psychol Bull 1980;87:108-31.
11. Rowland JH, Massie MJ. Psychologic reactions to breast cancer diagnosis, treatment, and survival. In: Harriss JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the Breast. Philadelphia: Lippincott-Raven Publishers, 1996: 919-38.
12. Stefanek ME. Psychosocial aspects of breast cancer. Curr Opin Oncol 1992;4:1055-60.
13. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-96.
14. McQuellon RP, Muss HB, Hoffman SL, Russell G, Craven B, Yellen SB. Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer.J Clin Oncol 1995;13:858-68.
15. Yellen SB, Cella DF. Someone to live for: social well-being, parenthood status, and decision-making in oncology.J Clin Oncol 1995;13:1255-64.
16. Kassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med 1994;330:1895-96.
17. Fallowfield LJ, Hall A, Maguire GP, Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ 1990;301: 575-80.
18. Alter CL. Palliative and supportive care of patients with pancreatic cancer. Semin Oncol 1996;23:229-40.
19. Campbell A, Converse PE, Rodgers WL. The Quality of American Life. New York: Sage, 1976.
20. Cella DF. Quality of life: concepts and definition.J Pain Symp Mgmnt 1994;9:186-92.
21. Cella DF. Quality of life: the concept. J Palliat Care 1992;8:8-13.
22. Osoba D. Lessons learned from measuring healthrelated quality of life in oncology.J Clin Oncol 1994;12:608-16.